ADVERTISEMENTs
Indian-origin professor joins editorial board of Diabetes
Ramakrishnan’s appointment to the board recognizes his significant contributions to immunological and metabolic research.
-
Malvika Choudhary1 - Wed, 23, Apr 2025
- 16:54 EDT
- 31
Parameswaran Ramakrishnan / Case Western Reserve University
Associate professor Parameswaran Ramakrishnan was appointed as a member of the editorial board of Diabetes, a journal published by the American Diabetes Association (ADA).
Published by the ADA, Diabetes is the top-ranked journal dedicated exclusively to diabetes research. It features peer-reviewed articles that advance understanding of the physiology and pathophysiology of diabetes mellitus, including type 1, type 2, gestational diabetes, and prediabetes.
Also Read: Satish Jha joins Octaga Green’s Board of Directors
Ramakrishnan’s appointment to the editorial board, for a three-year term spanning 2025 to 2027, recognizes his significant contributions to immunological and metabolic research, particularly in the context of inflammatory signaling pathways that are central to autoimmune conditions and diabetes-related complications.
An associate professor of pathology at Case Western Reserve University School of Medicine, Ramakrishnan also holds appointments in the department of biochemistry and the Immune Oncology Program at the Case Comprehensive Cancer Center.
In addition, he is a research biologist at the Louis Stokes Cleveland Veterans Affairs Medical Center and a faculty member in the Molecular Medicine doctorate program at the Cleveland Clinic’s Lerner Research Institute. His research focuses on signal transduction in immune cells, with a particular emphasis on NF-κB signaling pathways and inflammation.
Ramakrishnan has made key discoveries on how glucose metabolism and intracellular modifications regulate immune signaling—findings that have led to multiple international patents and continue to influence current investigations in immunometabolism.
A molecular immunologist by training, Ramakrishnan began his academic journey with a bachelor's in science and a master's in science in biotechnology from Mahatma Gandhi University, India. He contributed to an Indo-Swiss collaborative research project on genome diversity in Mycobacterium leprae before pursuing his doctorate at the Weizmann Institute of Science in Israel.
In 2008, Ramakrishnan joined the laboratory of Nobel Laureate Prof. David Baltimore at the California Institute of Technology. His research there advanced understanding of T cell survival, intracellular glycosylation (O-GlcNAcylation), and RNA-binding proteins like Sam68 in proinflammatory signaling—areas now central to ongoing studies in both immunology and metabolic disease.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
E Paper
ADVERTISEMENT
.jpg)
Video
.JPG)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login